chr1-155293438-C-T
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_000298.6(PKLR):βc.1269G>Aβ(p.Ala423Ala) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,614,098 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (β β ). Synonymous variant affecting the same amino acid position (i.e. A423A) has been classified as Pathogenic.
Frequency
Consequence
NM_000298.6 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKLR | ENST00000342741.6 | c.1269G>A | p.Ala423Ala | splice_region_variant, synonymous_variant | 8/11 | 1 | NM_000298.6 | ENSP00000339933.4 | ||
PKLR | ENST00000392414.7 | c.1176G>A | p.Ala392Ala | splice_region_variant, synonymous_variant | 8/11 | 1 | ENSP00000376214.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152206Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251466Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135906
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461892Hom.: 0 Cov.: 36 AF XY: 0.00000688 AC XY: 5AN XY: 727248
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152206Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74368
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jun 07, 2024 | The PKLR c.1269G>A; p.Ala423= variant (rs774652817, ClinVar ID: 1517), also known as PK βKamataβ, is reported in the literature, both as compound heterozygous and homozygous, in individuals with pyruvate kinase deficiency (Ayi 2008, Kanno 1997). In vitro functional analyses demonstrate skipping of exon 9 due to aberrant splicing, causing a deletion of 51 amino acids in the RBC subunit of PKLR (Kanno 1997). This variant is found in the general population with an overall allele frequency of 0.001% (3/282842 alleles) in the Genome Aggregation Database. Additionally, an alternative change at this position (c.1269G>C, p.Ala423=) has been reported in an individual with pyruvate kinase deficiency (Zanella 1997). This is a synonymous variant in a highly conserved nucleotide, and computational analyses (Alamut v.2.11) predict that this variant may impact splicing by weakening the nearby canonical donor splice site. Based on available information, this variant is considered to be pathogenic. References: Ayi K et al. Pyruvate kinase deficiency and malaria. N Engl J Med. 2008 Apr 24. PMID: 18420493. Kanno H et al. Frame shift mutation, exon skipping, and a two-codon deletion caused by splice site mutations account for pyruvate kinase deficiency. Blood. 1997 Jun 1. PMID: 9166866. Zanella A et al. Molecular characterization of PK-LR gene in pyruvate kinase-deficient Italian patients. Blood. 1997 May 15. PMID: 9160692. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Nov 30, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 24, 2022 | This variant disrupts a region of the PKLR protein in which other variant(s) (p.Glu407Lys) have been determined to be pathogenic (PMID: 16704447, 18759866). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in skipping of exon 8 (also referred to as exon 9 using alternate exon numbering), but is expected to preserve the integrity of the reading-frame (PMID: 9166866). ClinVar contains an entry for this variant (Variation ID: 1517). This variant has been observed in individual(s) with pyruvate kinase deficiency (PMID: 9166866, 18420493). This variant is present in population databases (rs774652817, gnomAD 0.006%). This sequence change affects codon 423 of the PKLR mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the PKLR protein. RNA analysis indicates that this variant induces altered splicing and likely results in a shortened protein product. For these reasons, this variant has been classified as Pathogenic. - |
Pyruvate kinase deficiency of red cells Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 24, 2008 | - - |
Pyruvate kinase deficiency of red cells;C1863224:Pyruvate kinase hyperactivity Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at